The Prostate Cancer Clinical Trials Consortium: Clinical Research Site Application

Abstract

The purpose of the PCCTC is to accelerate the development of novel therapeutics for prostate cancer patients, both by bringing own areas of expertise and contributing substantially to the activity of the consortium in the areas of biomarker development, androgen receptor targeted therapies, aggressive variant/neuroendocrine prostate cancer, and theranostics/novel molecular imaging. Results: During the reporting period, 32 patients were accrued across four PCCTC clinical trials, including three trials led by UCSF. One additional LOI was presented at the Scientific Oversight Committee for a PSMA-directed SBRT trial in oligometastatic CRPC.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2019
Accession Number
AD1092593

Entities

People

  • Rahul Aggarwal

Organizations

  • University of California, San Francisco

Tags

DTIC Thesaurus Topics

  • Androgen Receptors
  • Androgens
  • Biological Markers
  • Cancer
  • Clinical Trials
  • Consortiums
  • Department Of Defense
  • Detection
  • Diseases And Disorders
  • Institutional Review Board
  • Medical Personnel
  • Neoplasms
  • Nuclear Medicine
  • Oncology
  • Prostate
  • Prostate Cancer
  • Therapy

Fields of Study

  • Medicine

Readers

  • Clinical Trial Research.
  • Oncology
  • Prostate Cancer Biology.